1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account

First Indian vaccine manufacturer to successfully produce a thimerosal-free Hepatitis B Vaccine

A thimerosal-free hepatitis vaccine is preferred choice of pediatricians for birth dose vaccination of new born babies within 12 hours of birth.

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Oct 30, 2007 -
Bharat Biotech once again becomes the first Indian vaccine manufacturer to successfully produce Revac-Bmcf, a thimerosal -free Hepatitis B Vaccine and usher in an era of preferred vaccines. A thimerosal -free hepatitis vaccine is preferred choice of pediatricians for birth dose vaccination of new born babies within 12 hours of birth. The launch of Revac-Bmcf (thimerosal-free) at an affordable price by Bharat Biotech will also address the needs of parents and members of the medical fraternity who prefer the use of thimerosal -free vaccines.

Globally, Seven multinational companies (MNC’s) manufacture thimerosal -free vaccines such as Hepatitis B, Flu, Hepatitis A, DTaP, DTap+HepB+IPV, Hib, Hib+Hep B, HPV, IPV, MMR, MMR+Varicella, Pneumococcal, Rabies, Typhoid and Yellow Fever vaccines for use in markets worldwide. Bharat Biotech joins this elite club of vaccine manufacturers in developing, manufacturing and commercializing thimerosal -free vaccines. Several other vaccines in the current product line and future pipeline of Bharat Biotech will also be developed and commercialized in thimerosal -free presentations.  

Bharat Biotech has a successful track record of manufacturing a Thimerosal -free pediatric vaccine for a highly reputed MNC on a contract basis for overseas regulated markets. Having succeeded as the first Indian vaccine manufacturer to eliminate the use of Cesium chloride in Hepatitis B Vaccines, Bharat Biotech is forging ahead with a current portfolio of 10 injectable sterile preparations including 7 vaccines.  

Bharat Biotech has effectively optimized its production technologies to ensure the phasing out of thimerosal as a preservative wherever possible.

# # #

Bharat Biotech International Limited, Hyderabad, India, is a multidimensional biotechnology company specialising in product-oriented research, development and manufacturing of vaccines and bio-therapeutics.

The first bio-pharma company in the country to be audited and approved by Korean Food & Drugs Administration (KFDA), Bharat Biotech has set a new benchmark in Quality standards that epitomizes the tremendous progress of Indian biotechnology in the global arena.

--- end ---

Click to Share

Contact Email:
Source:Bharat Biotech International Limited
Website:http://www.bharatbiotech.com
Phone:914023480567
Address:Genome Valley, Shameerpet
Zip:500078
City/Town:Hyderabad
State/Province:Andhra Pradesh
Country:India
Industry:Biotech
Tags:thiomersal free, thimerosal free, hepatits b vaccine, , revac-bmcf, mecury component free vaccine
Shortcut:http://prlog.org/10035993
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share